. (2013). Characterization and aerosol dispersion performance of advanced spray-dried chemotherapeutic PEGylated phospholipid particles for dry powder inhalation delivery in lung cancer, European Journal of Pharmaceutical Sciences, 49(4), 699-711. doi: 10.1016/j.ejps.2013.05 amounts of paclitaxel in methanol to produce co-spray dried microparticles and nanoparticles.
7
in water (0.7 to 30 µg/ml) (Liggins et al., 1997) can be overcome via encapsulation into a solid-140 state particle system helping to overcome this major hurdle.
141
The objective of this systematic study was to rationally develop and characterize an 
MATERIALS AND METHODS

156
Materials
Scientific (Pittsburg, PA, USA). HYDRANAL @ -Coulomat AD was from Sigma-Aldrich (St.
165
Louis, MO, USA). Ultra-high purity (UHP) dry nitrogen gas was from Scott-Gross (Lexington, 166 KY, USA). All materials were used as received and stored at -20°C.
168
Spray-Drying and Co-Spray Drying from Dilute Drug Feed Solution
169
Advanced spray-drying of co-spray dried (co-SD) paclitaxel-loaded PEGylated phospholipid 170 particles was performed using a B-290 Büchi Mini Spray Dryer coupled with a B-295 Inert Loop 171 and high performance cyclone (all from Büchi Labortechnik AG, Switzerland) in closed-mode 172 using UHP dry nitrogen as the atomizing gas. The nozzle diameter (composed of stainless steel) 173 was 0.7 mm and the spray-drying (SD) particles were separated from the drying gas (using UHP 174 dry nitrogen) in the high-performance cyclone and collected in a sample collector. The feed 175 solutions were prepared by dissolving DPPC and DPPE-PEG (i.e. 95 mole % DPPC to 5 mole % 176 DPPE-PEG) with different amounts of paclitaxel (PTX) ranging from 5 to 75 mole% paclitaxel 177 to total DPPC/DPPE-PEG in methanol to form dilute concentration feed solutions of 0.1% w/v.
178
Based on our previous work (Li et al., 2011; Li and Mansour, 2011; Meenach et al., 2012b) , the 179 following spray-drying conditions were used: atomization gas flow rate of 600 L/h, aspiration 180 rate of 35 m 3 /h, inlet temperature of 150 °C (which represents the primary drying step), and 181 pump rate of 30 mL/min (High P). Table I shows the various formulated particle systems and 182 their corresponding PTX and DPPC/DPPE-PEG amounts and types and outlet temperatures 183 (which represent the secondary drying process temperatures). For pure spray dried (SD) 184 paclitaxel particles, the same atomization gas flow rate, aspiration rate, and inlet temperatures 185 were used as for the PEGylated phospholipid systems. The pump rate was varied at 3 mL/min 9 (Low P), 15 mL/min (Med P), and 30 mL/min (High P 
Particle Sizing and Size Distribution
200
The mean size, standard deviation, and size range of the particles were determined digitally using 
Powder X-ray Diffraction (XRPD)
224
XRPD patterns of powder samples were measured by a Rigaku Multiflex X-ray diffractometer
225
(The Woodlands, TX, USA) with a slit-detector Cu Kα radiation source (40 kV, 44 mA, and λ = 226 1.5406 Å). The scan range was 5 -50° in 2θ with a scan rate of 2°/min at ambient temperature.
227
The sample was placed on a horizontal quartz glass sample holder plate. respirable fraction (RF), and emitted dose (ED) were calculated as follows:
Fine particle dose (FPD) = mass of particles < 4.4 µm (Stages 2 through 7) experiments were triplicated (n = 3). slight decrease in size with increasing amounts of paclitaxel, although this was not significant.
320
There were no changes in the diameter due to the degree of PEGylation from DPPE-PEG.
321
Overall, the particles were within the ideal size range necessary for inhalation into the deep lung for both adults and children (Bosquillon et al., 2001; Coates and O'Callaghan, 2006) As seen in Figure 6a for the 5PTX particles, an endothermic main phase transition peak (T c ) was 340 observed between 63°C and 65°C for all samples which corresponds to the gel-to-liquid self- showed peaks throughout its diffractograms indicating its crystallinity prior to spray drying. 
Paclitaxel Loading
425
Paclitaxel loading into the PEGylated phospholipid dry powder particles was determined by 426 dissolving them in methanol and measuring the concentration of drug via UV-Vis spectroscopy.
427
As shown in Table I 
464
The MMAD values for most of the particle systems were within the range necessary (1 - 100PTX (Low P) 73 0.631 ± 0.265 2.28 ± 0.11 n/a n/a 100PTX (Med P) 81 0.624 ± 0.247 1.41 ± 0.38 n/a n/a 100PTX (High P) 41 0.672 ± 0.274 0.44 ± 0.39 n/a n/a 
